biostudies-literatureUnknown8(3)Dutra da Silva GMBrazilian Federal Agency for the Support and Evaluation of Graduate Education<h4>Aims</h4>To evaluate the prevalence of hypoactive sexual desire disorder (HSDD) among postmenopausal women diagnosed with metabolic syndrome (MS) and to compare it to that of a control group without MS.<h4>Methods</h4>This is a cross-sectional study carried out in 2 public tertiary hospitals in the state of São Paulo, Brazil, with a sample of 291 postmenopausal women aged between 40 and 65 years. Sexual function was evaluated using the Female Sexual Function Index (FSFI) questionnaire and Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, diagnostic criteria and was related to the diagnosis of MS, which was determined according to the guidelines defined by the Adult Treatment Panel.<h4>Main outcome measures</h4>Analysis of sexual function with emphasiSexual medicine545-553https://www.ebi.ac.uk/biostudies/studies/S-EPMC7471087biostudies-literaturePrevalence of Hypoactive Sexual Desire Disorder Among Sexually Active Postmenopausal Women With Metabolic Syndrome at a Public Hospital Clinic in Brazil: A Cross-sectional Study.PMC7471087Reis BFPostigo SMacruz CFDutra da Silva GMRolim Rosa Lima SMfalsePrevalence of Hypoactive Sexual Desire Disorder Among Sexually Active Postmenopausal Women With Metabolic Syndrome at a Public Hospital Clinic in Brazil: A Cross-sectional Study.<h4>Aims</h4>To evaluate the prevalence of hypoactive sexual desire disorder (HSDD) among postmenopausal women diagnosed with metabolic syndrome (MS) and to compare it to that of a control group without MS.<h4>Methods</h4>This is a cross-sectional study carried out in 2 public tertiary hospitals in the state of São Paulo, Brazil, with a sample of 291 postmenopausal women aged between 40 and 65 years. Sexual function was evaluated using the Female Sexual Function Index (FSFI) questionnaire and Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, diagnostic criteria and was related to the diagnosis of MS, which was determined according to the guidelines defined by the Adult Treatment Panel.<h4>Main outcome measures</h4>Analysis of sexual function with emphasi2020-01-01T00:00:00Z2020 Sep2025-04-05T07:22:30.536Z2020-09-13T07:06:54ZS-EPMC74710873259367510.1016/j.esxm.2020.05.008